PROMISSORY NOTE AMENDMENTPromissory Note Amendment • November 29th, 2013 • BK Consulting Inc • Bottled & canned soft drinks & carbonated waters • Nevada
Contract Type FiledNovember 29th, 2013 Company Industry JurisdictionThis Promissory Note Amendment (the “Amendment”) is entered into effective as of as of June 3, 2013 by and between BK Consulting Inc. (“Investor/Note-holder”) and Sport Endurance, Inc., a Nevada corporation (the “Company”), with reference to the following facts:
PROMISSORY NOTE AMENDMENTPromissory Note Amendment • August 16th, 2004 • Impac Mortgage Holdings Inc • Real estate investment trusts
Contract Type FiledAugust 16th, 2004 Company IndustryThis Promissory Note Amendment by and between Impac Funding Corporation (“Maker”) and Impac Mortgage Holdings, Inc. (“Holder”) is made and executed effective as of June 30, 2004 (the “Amendment”).
PROMISSORY NOTE AMENDMENTPromissory Note Amendment • May 23rd, 2011 • PediatRx Inc. • Pharmaceutical preparations
Contract Type FiledMay 23rd, 2011 Company IndustryThis Promissory Note Amendment (this “Amendment”) is made and entered into as of the 23rd day of May, 2011 (the “Amendment Date”), by and between Benjamin Company S.A. with principal offices located at Saffrey Square, Nassau Bahamas, (“Noteholder”) and PediatRx, Inc., with principal offices located at 405 Trimmer Road, Suite 200, Califon, NJ, 07830 USA (“Company”).
PROMISSORY NOTE AMENDMENTPromissory Note Amendment • May 18th, 2012 • PediatRx Inc. • Pharmaceutical preparations
Contract Type FiledMay 18th, 2012 Company IndustryThis Promissory Note Amendment (this “Amendment”) is made and entered into as of the 19 day of April, 2011 (the “Amendment Date”), by and between Trels Investments, Ltd. with principal offices located at 17 Gr. Xenopoulou Street, PO Box 54425, 3724 Limassol, Cypress (“Noteholder”) and PediatRx, Inc., with principal offices located at 90 Fairmount Road West, Califon, NJ, 07830 USA (“Company”).
PROMISSORY NOTE AMENDMENTPromissory Note Amendment • July 31st, 2012 • PediatRx Inc. • Pharmaceutical preparations
Contract Type FiledJuly 31st, 2012 Company IndustryThis Promissory Note Amendment (this “Amendment”) is made and entered into as of the 25th day of July, 2012 (the “Amendment Date”), by and between Trels Investments, Ltd. with principal offices located at 17 Gr. Xenopoulou Street, PO Box 54425, 3724 Limassol, Cypress (“Noteholder”) and PediatRx Inc., with principal offices located at 90 Fairmount Road West, Califon, NJ, 07830 USA (“Company”).
PROMISSORY Note AmendmentPromissory Note Amendment • December 28th, 2020 • Verus International, Inc. • Wholesale-groceries, general line
Contract Type FiledDecember 28th, 2020 Company IndustryThis special amendment (the “Special Amendment”) is made as of the Effective Date indicated above the signature lines below, between ACG Global Solutions Inc. (“ACG”) and Verus International Inc. (“Verus”).
PROMISSORY NOTE AMENDMENTPromissory Note Amendment • April 24th, 2024 • Comstock Inc. • Industrial organic chemicals • Nevada
Contract Type FiledApril 24th, 2024 Company Industry JurisdictionThis Promissory Note Amendment (this “Amendment”), dated as of April 22, 2024, is entered into by and between Comstock Inc., a Nevada corporation (the “Borrower”), and Alvin Fund LLC (“Lender”). Capitalized terms used in this Amendment but not otherwise defined herein shall have the respective meanings ascribed to them in the Promissory Note (as defined below).
PROMISSORY NOTE AMENDMENTPromissory Note Amendment • September 26th, 2013 • Quint Media Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 26th, 2013 Company IndustryThis Promissory Note Amendment (this “Amendment”) is made and entered into as of August 31, 2013, by and between Trels Investments, Ltd. (the “Noteholder”), having a principal business address of 17 Gr. Xenopoulou Street, PO Box 54425, 3724 Limassol, Cypress and Quint Media Inc. (the “Company”), with a principal business address of 3250 NE 1st Ave., Suite 305, Miami, FL 33137.
PROMISSORY NOTE AMENDMENTPromissory Note Amendment • July 27th, 2012 • PediatRx Inc. • Pharmaceutical preparations
Contract Type FiledJuly 27th, 2012 Company IndustryThis Promissory Note Amendment (this “Amendment”) is made and entered into as of the 25th day of July, 2012 (the “Amendment Date”), by and between Benjamin Company S.A. with principal offices located at Saffrey Square, Nassau Bahamas, (“Noteholder”) and PediatRx Inc., with principal offices located at 90 Fairmount Road West, Califon, NJ, 07830 USA (“Company”).
PROMISSORY NOTE AMENDMENTPromissory Note Amendment • April 24th, 2024 • Comstock Inc. • Industrial organic chemicals • Nevada
Contract Type FiledApril 24th, 2024 Company Industry JurisdictionThis Promissory Note Amendment (this “Amendment”), dated as of April 22, 2024, is entered into by and between Comstock Inc., a Nevada corporation (the “Borrower”), and GHF, Inc. (“Lender”). Capitalized terms used in this Amendment but not otherwise defined herein shall have the respective meanings ascribed to them in the Promissory Note (as defined below).
PROMISSORY NOTE AMENDMENTPromissory Note Amendment • September 26th, 2013 • Quint Media Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 26th, 2013 Company IndustryThis Promissory Note Amendment (this “Amendment”) is made and entered into as of August 31, 2013, by and between Trels Investments, Ltd. (the “Noteholder”), having a principal business address of 17 Gr. Xenopoulou Street, PO Box 54425, 3724 Limassol, Cypress and Quint Media Inc. (the “Company”), with a principal business address of 3250 NE 1st Ave., Suite 305, Miami, FL 33137.
PROMISSORY NOTE AMENDMENTPromissory Note Amendment • July 31st, 2012 • PediatRx Inc. • Pharmaceutical preparations
Contract Type FiledJuly 31st, 2012 Company IndustryThis Promissory Note Amendment (this “Amendment”) is made and entered into as of the 25th day of July, 2012 (the “Amendment Date”), by and between Trels Investments, Ltd. with principal offices located at 17 Gr. Xenopoulou Street, PO Box 54425, 3724 Limassol, Cypress (“Noteholder”) and PediatRx Inc., with principal offices located at 90 Fairmount Road West, Califon, NJ, 07830 USA (“Company”).
PROMISSORY NOTE AMENDMENTPromissory Note Amendment • May 18th, 2011 • PediatRx Inc. • Pharmaceutical preparations
Contract Type FiledMay 18th, 2011 Company IndustryThis Promissory Note Amendment (this “Amendment”) is made and entered into as of the 18 day of MAY, 2011 (the “Amendment Date”), by and between Trels Investments, Ltd. with principal offices located at 17 Gr. Xenopoulou Street, PO Box 54425, 3724 Limassol, Cypress (“Noteholder”) and PediatRx, Inc., with principal offices located at 405 Trimmer Road, Suite 200, Califon, NJ, 07830 USA (“Company”).
PROMISSORY NOTE AMENDMENTPromissory Note Amendment • April 24th, 2024 • Comstock Inc. • Industrial organic chemicals • Nevada
Contract Type FiledApril 24th, 2024 Company Industry JurisdictionThis Promissory Note Amendment (this “Amendment”), dated as of April 22, 2024, is entered into by and between Comstock Inc., a Nevada corporation (the “Borrower”), and Alvin Fund LLC (“Lender”). Capitalized terms used in this Amendment but not otherwise defined herein shall have the respective meanings ascribed to them in the Promissory Note (as defined below).
PROMISSORY NOTE AMENDMENTPromissory Note Amendment • April 20th, 2016 • Surna Inc. • Services-business services, nec
Contract Type FiledApril 20th, 2016 Company IndustryTHIS PROMISSORY NOTE AMENDMENT (the “Amendment”) is made this 15th day of April, 2016 (the “Effective Date”), by and among, SURNA INC., a Nevada Corporation (“Debtor”), STEPHEN KEEN, an individual, and BRANDY KEEN, an individual (collectively, the “Holders”).
PROMISSORY NOTE AMENDMENTPromissory Note Amendment • May 18th, 2012 • PediatRx Inc. • Pharmaceutical preparations
Contract Type FiledMay 18th, 2012 Company IndustryThis Promissory Note Amendment (this “Amendment”) is made and entered into as of the 19 day of April, 2011 (the “Amendment Date”), by and between Trels Investments, Ltd. with principal offices located at 17 Gr. Xenopoulou Street, PO Box 54425, 3724 Limassol, Cypress (“Noteholder”) and PediatRx, Inc., with principal offices located at 90 Fairmount Road West, Califon, NJ, 07830 USA (“Company”).